Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Prolactin may affect hair growth differently based on gender and scalp area.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Early diagnosis and treatment of TPP can prevent complications.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

Hair loss in women links to inflammation around hair follicles.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.